Intel Capital emerges as strategic investor in Gaikai’s series B round in May.
Month: July 2010
Safeguard sets NuPathe flotation price
NuPathe, a US-based drug developer focused on the central nervous system, is preparing to list five million shares at between $14 and $16 each with an initial market capitalisation of $225m.
Qualcomm validates company’s D round
Qualcomm Ventures, the corporate venturing division of US telecoms equipment maker Qualcomm, part of consortium investing $12.6m in Validity.
Green Dot floats above expectations
Shareholders in prepaid debit card provider Green Dot raised a more-than-expected $164.1m at its flotation.
Integrated Diagnostics scores second funding tranche
BioTechCube (BTC), a newly-formed Luxembourg-based investment company backed by the state, replaced dievini Hopp BioTech as $10m is drawn down from Integrated Diagnostics’ $30m series A round.
Novartis co-leads Euthymics A round
Euthymics Bioscience, a US-based developer of antidepressants, raises $24m from Novartis and venture capital firms to acquire DOV and develop drugs.
Physic leaps on Gazelle series C
Physic Ventures, a venture capital firm backed by consumer goods companies Pepsi and Unilever, leads $12m third funding round for Gazelle, a US-based company for selling secondhand electronics goods.
Cara gains $15m funding relief
Venture consortium continues to support Cara Therapeutics in its series D round after more than $55m in five year.
Google backs search advertising peer
Trada, a US-based company which helps businesses with online search advertising, gains $5.75m in third funding round in 18 months.
IDG plans two more Vietnam-focused funds
US-based publisher International Data Group’s corporate venturing group set to expand its successful first fund in Vietnam by committing a further $400m.
Korea Telecom launches $800m fund
Korea-based venture capital firm Woongjin Capital to manage Mobile Korea Renaissance Fund on behalf of country’s main phone operator.
Sorbent soaks up funding success
US regulatory filing shows Sorbent Therapeutics gains nearly maximum round to treat renal problems.
LedEngin gains funding success
Taiwan connections seal series D round for light-emitting diode (LED) company.
TranSwitch exits Opulan
US communications equipment company TranSwitch sees venture stake in China-based Opulan Technologies realised through $72m sale to Atheros Communications.